QAS.AI provides AI-driven software that aids surgeons in modifying aneurysm treatment plans in real-time during procedures. The software helps detect inadequate blood flow and predicts treatment efficacy six months post-embolization. It processes angiographic parametric imaging to assess tissue perfusion and detect ischemia with high accuracy, allowing for timely clinical decision-making. With minimal disruption to workflow, QAS.AI significantly enhances the diagnosis and treatment outcomes related to aneurysms, leveraging data from thousands of patients for accurate predictions.
• minimal disruption to clinical workflows
• automated assessment of tissue perfusion and vessel occlusion
• detects areas of ischemia with 90% accuracy
• predicts treatment outcomes six months post-procedure
• real-time monitoring during surgeries
Average Rating: 0.0
5 Stars:
0 Ratings
4 Stars:
0 Ratings
3 Stars:
0 Ratings
2 Stars:
0 Ratings
1 Star:
0 Ratings
No ratings available.
A federated AI framework that integrates decentralized data sources for AI development.
View Details